Investor Relations OBJ Limited
DATA NAVIGATION

All Company Announcements

ASXHosted by ASX
View all announcements here.
Contains a complete list of all corporate announcements and scientific results.


Current Share Price

OBJ on Boardroom Radio

Monday, 24 April 2006 3:30 PM

Jeff Edwards (Technical Director) speaks on Boardroom Radio about OBJ Limited and the breakthrough Tetracaine Human Pilot Study.

Click here to listen to the interview.

Read about the Tetracaine Human Pilot study.
Read about OBJ Limited's Clinical Studies.

 Introduction Proof of Concept

- Tetracaine

Capabilities

- 5-aminolevulinic acid (5-ALA)

- Hydrocortisone

- Naltrexone Hydrochloride

- Caffeine

- Vaccines

How does it work What are the benefits
 
Who is OBJ
 
Investor Relations Corporate Team Scientific Team Contact Directory

 Download our 2007 Annual Report here

Right-click and save as...
Home  |  Capabilities  |  About OBJ Limited  |  Investor Relations  |  Contact Directory